ChemoMetec A/S (CPSE: CHEMM)
Health Care · Life Sciences Tools & Services · DK
Dkr567.50
-2.16% today · -18.3% 1Y
ChemoMetec A/S (CPSE: CHEMM) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $1.46B and employs 174 people.
Over the last twelve months the share price has lost 18.3%, trading between 235.20 and 804.00.
Tweenvest scores ChemoMetec A/S across four factors: quality 81/100, value 34/100, growth 62/100. Its strongest factor is quality.
CHEMM price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.46B
- Revenue (TTM)
- $78.10M
- P/E
- 48.92
- EPS
- 11.60
- Dividend yield
- —
- Beta (5Y)
- 1.37
- 52-week high
- Dkr804.00
- 52-week low
- Dkr235.20
- Avg volume (3M)
- —
- Shares outstanding
- 17.20M
- Employees
- 174
- Next earnings
- —
About ChemoMetec A/S
Headquartered in Allerød, Denmark, and established in 1997, ChemoMetec A/S focuses on the design, production, and worldwide distribution of analytical instruments for cell enumeration and analysis. Their sophisticated solutions are utilized across diverse fields, including cell-based therapeutics, oncology and stem cell research, pharmaceutical development and manufacturing, along with quality assurance for animal semen and beer. The company's product offerings feature a range of NucleoCounter devices, such as the NC-3000 advanced image cytometer, the NC-250 automated cell analyzer, and the consistent NC-202 and NC-200 automated cell counters for viability assessment. Specialized counters include the NucleoCounter SP-100 for automated sperm cell analysis in animal production, the SCC-100 for measuring somatic cells in milk samples, and the YC-100 for total count and viability of yeast cells. Beyond equipment, they also supply vital consumables like cassettes and reagents, various accessories such as software and cables, and offer extensive service and validation plans.
- ISIN
- DK0060055861
- Founded
- 1997
- Listed since
- Dec 18, 2006
- Exchange
- OMX Nordic Exchange Copenhagen
- Currency
- DKK
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Personalis, Inc.NasdaqGM: PSNL | $1.71B | $16.00 | -0.19% |
| Azenta, Inc.NasdaqGS: AZTA | $1.57B | $35.89 | -8.79% |
| Syngene International LimitedNSEI: SYNGENE | $1.49B | Rs361.30 | -4.59% |
| Indegene LimitedNSEI: INDGN | $1.48B | Rs593.50 | -2.54% |
| Akums Drugs and Pharmaceuticals LimitedNSEI: AKUMS | $1.29B | Rs813.10 | -0.79% |
| Beijing Hotgen Biotech Co., Ltd.SHSE: 688068 | $1.24B | CN¥94.47 | +2.81% |
| Novogene Co., Ltd.SHSE: 688315 | $1.19B | CN¥19.77 | -3.09% |
| Maravai LifeSciences Holdings, Inc.NasdaqGS: MRVI | $1.18B | $7.43 | -5.95% |
Figures last refreshed Oct 4, 2026.